291 SynthEtic LEthal Cancer Therapy in mesothelioma (SELECTmeso): a molecularly stratified multi-arm phase II platform trial for patients with relapsed malignant mesothelioma
Fields of Study & Subjects
Occupational and environmental lung diseases
Intraperitoneal and Appendiceal Malignancies
Lung Cancer Treatments and Mutations
Publication details
- Journal / source
- Lung Cancer
- Volume
- 212
- Pages
- 109239–109239
- Publication date
- 1 February 2026
- Language
- EN